BioStem Technologies, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BSEM for the last quarter is 82.56 M USD, and it's 10.83% higher compared to the previous quarter. The net income of Q3 24 is 6.82 M USD.